Genetic mutations in two previously unrecognized genes, the microtubule-associated protein tau (MAPT) and BNIP1 genes, are associated with elevated risk for amyotrophic lateral sclerosis (ALS). As seen in other neurodegenerative diseases, abnormal accumulation of toxic proteins seems to play a role in ALS onset and progression. Different mutations in tau protein previously were associated with other neurodegenerative diseases, such as Alzheimer’s. However, the specific mutation identified in this study was associated only with ALS, and not with the other diseases included in the study. Genetic mutations that modestly elevate risk for ALS were identified with more than two dozen different genes.
Read the Full Story at alsnewstoday.com
ALS Study Reveals Two Genes Associated with High Risk for Disease
More from ResearchMore posts in Research »
- A possible blood test for early-stage Alzheimer’s disease | Medical Xpress
- Blood Biomarkers Plus Gene Status Predict Cognitive Decline : Neurology Today
- Early Detection of Alzheimer’s Prior to Onset of Symptoms Now Possible | Science Times
- We Need New Ideas for Fighting Alzheimer’s | Scientific American
- Immune view offers clues to early Alzheimer’s